
OrthoPediatrics rose 93.6% from $16.35 to $31.65, ahead of the S&P 500's +10.6%. Its worst day was Apr 16 (−7.4%), and its low came Apr 29 at $14.64.
Nov 18, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
OrthoPediatrics (NASDAQ:KIDS) raises FY2025 sales outlook from $233.500 million-$234.500 million to $236.100 million vs $234.002 million estimate.
+9.8% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
EPS of $-0.26 beat the $-0.32 estimate on $61.6M revenue (est. $61.3M); FY revenue guidance of $262.0M–$266.0M against the $263.0M consensus.
+7.8% · S&P 500 −0.5%
EPS of $-0.42 beat the $-0.43 estimate on $59.4M revenue (est. $58.3M); FY revenue guidance of $263.0M–$267.0M against the $264.3M consensus.
+3.8% · S&P 500 +0.3%
EPS of $-0.26 beat the $-0.29 estimate on $70.5M revenue (est. $68.2M); FY revenue guidance of $265.0M–$269.0M against the $265.1M consensus.
+6.8% · S&P 500 −0.2%
EPS of $-0.23 missed the $-0.22 estimate on $72.7M revenue (est. $68.5M); FY revenue guidance of $270.0M–$273.0M against the $267.0M consensus.
+29.3%, the year's best day, on 2M shares, the year's heaviest volume · S&P 500 +0.3%
OrthoPediatrics closed at its highest level of the year, 107.9% above where the year started.
+7.0% · S&P 500 +2.4%
Where it ended: a close of $31.65 on Nov 18, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-0.19, revenue est. $69.1M).
Nothing in the past 12 months.
All KIDS dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for KIDS and SPY from Benzinga historical bars. Not investment advice.